NasdaqGS - Delayed Quote • USD
Neogen Corporation (NEOG)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:59 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 0.11 | 0.12 | 0.46 | 0.55 |
Low Estimate | 0.11 | 0.12 | 0.46 | 0.55 |
High Estimate | 0.11 | 0.12 | 0.46 | 0.55 |
Year Ago EPS | 0.14 | 0.11 | 0.56 | 0.46 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | 224.75M | 228.85M | 912.21M | 937.56M |
Low Estimate | 222.71M | 226.1M | 910.13M | 935.53M |
High Estimate | 226.8M | 231.6M | 914.3M | 939.6M |
Year Ago Sales | 241.81M | 231.1M | 822.45M | 912.21M |
Sales Growth (year/est) | -7.10% | -1.00% | 10.90% | 2.80% |
Earnings History
CURRENCY IN USD | 5/31/2023 | 8/31/2023 | 11/30/2023 | 2/29/2024 |
---|---|---|---|---|
EPS Est. | -0.03 | 0.12 | 0.14 | 0.14 |
EPS Actual | 0.14 | 0.11 | 0.11 | 0.12 |
Difference | 0.17 | -0.01 | -0.03 | -0.02 |
Surprise % | 566.70% | -8.30% | -21.40% | -14.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.11 | 0.12 | 0.46 | 0.55 |
7 Days Ago | 0.11 | 0.12 | 0.46 | 0.55 |
30 Days Ago | 0.17 | 0.17 | 0.54 | 0.72 |
60 Days Ago | 0.17 | 0.18 | 0.54 | 0.77 |
90 Days Ago | 0.17 | 0.18 | 0.54 | 0.77 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | NEOG | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -21.40% | -- | -- | 5.40% |
Next Qtr. | 9.10% | -- | -- | 10.90% |
Current Year | -17.90% | -- | -- | 4.50% |
Next Year | 19.60% | -- | -- | 13.10% |
Next 5 Years (per annum) | 10.00% | -- | -- | 10.94% |
Past 5 Years (per annum) | -7.33% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Piper Sandler: Neutral to Neutral | 4/15/2024 |
Maintains | Piper Sandler: Neutral to Neutral | 1/18/2024 |
Maintains | Piper Sandler: Neutral to Neutral | 10/16/2023 |
Maintains | Wells Fargo: Overweight to Overweight | 8/14/2023 |
Initiated | Wells Fargo: Overweight | 6/16/2023 |
Maintains | Piper Sandler: Neutral | 12/15/2022 |
Related Tickers
SHC Sotera Health Company
11.40
+0.71%
GH Guardant Health, Inc.
17.35
+1.11%
NEO NeoGenomics, Inc.
14.14
+2.09%
CRL Charles River Laboratories International, Inc.
229.03
+0.54%
XGN Exagen Inc.
1.4121
+0.86%
ICLR ICON Public Limited Company
308.31
+2.74%
MTD Mettler-Toledo International Inc.
1,238.09
+0.42%
OCX OncoCyte Corporation
2.4800
+1.64%
MYGN Myriad Genetics, Inc.
18.18
+1.11%
QGEN Qiagen N.V.
41.65
+1.39%